FIELD: medicine.
SUBSTANCE: clinical-laboratory and functional methods are used to determine diagnostic criteria and to calculate a prognostic index. A complex of the following diagnostic criteria is determined in a patient: anthropometric - a Quetelet index, a lipid metabolism - an atherogenic index of apoprotein, a functional hepatic state - alanine aminotransferase, lipid peroxidation - a relation of malondialdehyde to the antioxidant activity, central haemodynamic values - a systolic arterial blood pressure and cardiac index. A predictive index determining a degree of manifestation of metabolic disorders is the prognostic index as the total value of the diagnostic criteria determined by clinical-laboratory and functional methods and calculated by formula. The value derived from formula is used to predict no risk of metabolic syndrome, a low risk, a moderate risk and a high risk of metabolic syndrome.
EFFECT: method enables predicting the manifestation of metabolic syndrome by assessing the diagnostic criteria and conducting timely therapy for the purpose of preventing metabolic syndrome and cardiovascular complications.
3 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR METABOLIC SYNDROME PREDICTION IN THE II TRIMESTER OF PREGNANCY | 2016 |
|
RU2617182C1 |
METHOD FOR CORRECTION OF LIPOPEROXIDATION ACCOMPANYING HYPOLIPIDEMIC THERAPY OF PATIENTS WITH METABOLIC SYNDROME | 2011 |
|
RU2458687C1 |
METHOD FOR INSULIN RESISTANCE CORRECTION IN METABOLIC SYNDROME | 2009 |
|
RU2402326C1 |
METHOD OF RISK EVALUATION OF METABOLIC SYNDROME IN PATIENTS WITH CHRONIC CHOLECYSTITIS | 2009 |
|
RU2403868C1 |
METHOD OF MEDICAL REHABILITATION OF PATIENTS SUFFERING ARTERIAL HYPERTENSION WITH METABOLIC DISORDERS | 2008 |
|
RU2403922C2 |
METHOD FOR PREDICTING ISCHEMIC CARDIAC DISEASE IN PATIENTS WITH ARTERIAL HYPERTENSION | 2006 |
|
RU2316995C1 |
METHOD FOR METABOLIC SYNDROME CORRECTION WITH USE OF MARE'S MILK AND HYPOBAROTHERAPY | 2012 |
|
RU2472514C1 |
METHOD FOR ULTRASOUND DIAGNOSTICS OF METABOLIC PHENOTYPE OF ABDOMINAL OBESITY | 2020 |
|
RU2751972C1 |
METHOD FOR SELECTING PROBATIONERS OF CHEMICAL PRODUCTION IN GROUP OF HIGH RISK OF DEVELOPING CONDITIONED CARDIORESPIRATORY PATHOLOGY | 2020 |
|
RU2742342C1 |
METHOD FOR VERIFYING CHRONIC HEPATIC PATHOLOGY IN PATIENTS WITH ARTERIAL HYPERTENSION | 2013 |
|
RU2547246C1 |
Authors
Dates
2014-10-10—Published
2013-09-10—Filed